ET by Tomi Kilgore. Energy. The estimated additional pay is $40,980 per year. Minimum 15 minutes delayed. What is the Price-to-Book ratio of Singular Genomics Systems Inc? The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Raising the bar with industry-leading run times across applications. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. To explore Singular Genomicss full profile, request access. 2023 Singular Genomics. Get the full list, Youre viewing 5 of 6 board members. 326 E 8th St #105, Sioux Falls, SD 57103 What is Singular Genomics Systems Inc's EBITDA? Seed, Series A, Private Equity), Alternate or previous names for the organization, Whether an Organization is for profit or non-profit, General contact email for the organization. Construction and Engineering. Should I buy or sell Singular Genomics Systems stock right now? It develops two integrated solutions: G4 Instrument and PX Instrument. Investor Contact Matt Clawson +949-370-8500 ir@singulargenomics.com. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Chemicals. View analysts price targets for OMIC or view top-rated stocks among Wall Street analysts. Contact Email info@singulargenomics.com. Certain statements contained in this press release, other than historical information, constitute forward-looking statements within the meaning of the federal securities laws. Follow Us. Founders Drew Spaventa, Eli Glezer. According to the current price, Singular Genomics Systems is 112.04% away from the 52-week low. Singular Genomics Systems, Inc. (Name of Issuer) Common Stock par value $0.0001 per share (Title of Class of Securities) 82933R100 . A high-level overview of Singular Genomics Systems, Inc. (OMIC) stock. Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. What is Singular Genomics Systems Inc stock price today? It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. The data displayed in the quote bar updates every 3 seconds; allowing you to monitor prices in real-time. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.24) by $0.01. Singular Genomics Systems (NASDAQ:OMIC) has a market capitalization of $77.70 million and generates $760,000.00 in revenue each year. USD. Singular Genomics first integrated solution is targeted at the NGS market and comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the G4 Integrated Solution. How many employees does Singular Genomics Systems have? mesurer votre utilisation de nos sites et applications. Singular Genomics . What is the PE ratio of Singular Genomics Systems Inc? The average price target is $2.25 with a high forecast of $2.25 and a low forecast of $2.25. Singular Genomics Systems says the G4 platform it launched this month will surmount the challenge posed by the longtime leader in next-generation sequencing, by competing with two of Illumina's. Support +1 (442) 742-2737 support@singulargenomics.com. Investors may trade in the Pre-Market (4:00-9:30 a.m. Legal Name Singular Genomics Systems, Inc. Stock Symbol NASDAQ:OMIC. Revenue was comprised predominantly of the revenue recognized on three instrument placements during the quarter. These risks and uncertainties include and are not limited to the following: (i) we have incurred significant losses since inception, we expect to incur significant losses in the future and we may not be able to generate sufficient revenue to achieve and maintain profitability; (ii) we have very little history manufacturing and commercializing our products or technology; (iii) the life sciences technology market is highly competitive, and if we fail to compete effectively, our business and operating results will suffer; (iv) if we are sued for infringing, misappropriating or otherwise violating intellectual property rights of third parties, such litigation could be costly and time consuming and could prevent or delay us from developing or commercializing our products; (v) if our products fail to achieve early customer and scientific acceptance, we may not be able to achieve broader market acceptance for our products, and our revenues and prospects may be harmed; (vi) we expect to be highly dependent upon revenue generated from the sale of the G4 and planned PX, and any delay or failure by us to successfully manufacture and commercialize the G4 and planned PX could have a substantial adverse effect on our business and results of operations; and (vii) the COVID-19 pandemic, efforts to reduce its spread and recent macroeconomic challenges have adversely impacted, and may materially and adversely impact, our business, operations and product manufacturing and commercialization objectives. The estimated base pay is $141,278 per year. Peer performance insights compare the companys ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements. On September 30, 2021 (the Closing Date), Singular Genomics Systems, Inc. refinanced its existing loan with Silicon Valley Bank (the "Lender"). Stoke Therapeutics Inc. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS Investment Bank acted as the underwriters for the IPO. hbspt.forms.create({ View our OMIC earnings forecast. Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Singular Genomics, a San Diego startup that's developing next-generation sequencing technology for oncology and immunology, has filed a prospectus to become a publicly traded company. This impressive SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the fourth quarter and full year ended December 31, 2022. Initial Registration Statement for Employee Benefit Plan . This suggests a possible upside of 224.1% from the stock's current price. The company can be reached via phone at 858-333-7830. Its calculated by averaging the closing stock price over the previous 50 trading days. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and . We are purposeful and collaborative in our approach. We are at AACR 2023! In 2023, we will remain focused on customer success across a growing installed base, commercial and operational execution, and advancing our innovation pipeline.. (844) 978-6257. Their OMIC share price forecasts range from $3.00 to $4.50. 3010 Science Park Rd San Diego, CA 92121 . Operating Status Active. What is Singular Genomics Systems' stock price today? Any such forward-looking statements are based on our managements current expectations and are subject to risks and uncertainties that could cause our actual future results to differ materially from our managements current expectations or those implied by our forward-looking statements. Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. It's fairly readable and I recommend taking a look if that . System throughput depends on sequencing application and flow cell. The year-over-year increase in operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Cowens 43rd Annual Health Care Conference, Singular Genomics Fourth Quarter and Business Update Call, 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights and First Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics Systems, Inc. to Report Third Quarter 2021 Financial Results. Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2022 . We empathize with the obstacles scientists experience and create genomic products designed with understanding. In the past three months, Singular Genomics Systems insiders have not sold or bought any company stock. Company Type For Profit. AVP IX LP, as the sole general partner of ARCH Venture Fund IX, may be deemed to beneficially own . What is Singular Genomics Systems' stock symbol? The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. This information is available in the PitchBook Platform. Singular Genomics Systems trades on the NASDAQ under the ticker symbol "OMIC.". Data reflects weightings calculated at the beginning of each month. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OMIC, but not buy additional shares or sell existing shares. Singular Genomics Systems Inc 50-day moving average is $1.75. When is Singular Genomics Systems' next earnings date? Singular Genomics Systems has a P/B Ratio of 0.30. Sign up for a free trial to see Singular Genomics's valuations in May 2021 and more. EBITDA is a widely used measure of corporate profitability. Singular Genomics Systems Inc 52 week high is $5.21 as of April 18, 2023. 2023 Singular Genomics. Singular Genomics Systems Inc 50-day moving average is $1.71. The investment bank also lowered its price target to $4.50 from $10 per share. It can also be calculated by dividing the companys Market Cap by the Net Profit. Singular Genomics management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Register for your free account today atdata.nasdaq.com. Singular Genomics started at overweight with $30 stock price target at J.P. Morgan. 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Singular Genomics Systems in the last twelve months. Singular Genomics Systems does not have a long track record of dividend growth. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. Company News. Singular Genomics Systems Inc (OMIC) stock is trading at $1.17 as of 1:47 PM on Monday, Apr 10, a loss of -$0.11, or -8.59% from the previous closing price of $1.28. Can Garrett Motion Turbocharge A Short Squeeze? Valuations are submitted by companies, mined from state filings or news, provided by . Its calculated by dividing the current share price by the earnings per share (or EPS). Mar 02, 2023. Singular Genomics's latest post-money valuation is from May 2021. How were Singular Genomics Systems' earnings last quarter? When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. 10X GENOMICS, INC. : Nieuws en informatie aandeel 10X GENOMICS, INC. | 1KJ | Deutsche Boerse AG About Singular Genomics Systems, Inc. 10931 NORTH TORREY PINES ROAD SUITE NO.100, LA JOLLA, California, 92037, United States +1 858 333-7830 https://www.singulargenomics.com. The G4 Sequencing Platform is designed to target the NGS market. Agriculture. The company issued 8,500,000 shares at $20.00-$22.00 per share. Accordingly, you should not rely on forward-looking statements as predictions of future events or our future performance. An innovative benchtop sequencing platform with novel, high-performance chemistry and advanced engineering, optimized to deliver unmatched power, speed, and versatility. target: "#hbspt-form-1681761025000-5259139204", Get the latest Singular Genomics Systems Inc (OMIC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Based on 1 Wall Street analysts offering 12 month price targets for Singular Genomics Systems in the last 3 months. Singular Genomics Systems has received a consensus rating of Hold. All rights reserved. What is Market Cap of Singular Genomics Systems Inc? Create your Watchlist to save your favorite quotes on Nasdaq.com. It attempts to reflect the cash profit generated by a companys operations. A lower score indicates better sustainability, Exposure refers to the extent to which a company is exposed to different material ESG issues, Management is related to actions taken to manage ESG issues. Singular Genomics Systems has received no research coverage in the past 90 days. Their OMIC share price forecasts range from $3.00 to $4.50. Could The Singular Genomics Systems, Inc. (NASDAQ:OMIC) Ownership Structure Tell Us Something Useful? 52 week low is the lowest price of a stock in the past 52 weeks, or one year. portalId: 20463371, , Key events shows relevant news articles on days with large price movements, Trkiye's BIST 100 opens Tuesday on high note, Turkish stock exchange closes Monday in red, Dow Futures Edge Up Ahead of Bank Earnings, Advanced Oncotherapy Seeks Nasdaq Quoted Buyer, Stock Market Today: Dow, S&P Live Updates for April 18. Singular Genomics Systems, Inc. (OMIC) Q2 2022 Earnings Call Transcript, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, One Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider upped their stake by 16% in the previous year, Singular Genomics in pact with TwinStrand Biosciences for next gen sequencing, view top-rated stocks among Wall Street analysts, 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. See disclosure here. 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Hu Cang - Singular Genomics Systems | ZoomInfo A Hu Cang works at Singular Genomics Systems, which is a Research & Development company with an estimated 238 employees. Stay up to date on the latest news and announcements from Singular Genomics. Intentionally designed to alleviate challenges faced by researchers in the lab today, the G4 Sequencing Platform features advanced engineering and novel chemistry to deliver faster results, with more operational flexibility. Win whats next. This is a profile preview from the PitchBook Platform. What is the 52-week low for Singular Genomics Systems Inc? May-26-21 11:56PM. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. After all, the newsletter they have run for over a decade . Stay Connected Get the latest Singular Genomics Systems, Inc. (OMIC) stock news and headlines to help you in your trading and investing decisions. The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. Our daily ratings and market update email newsletter. There are currently 1 sell rating and 2 hold ratings for the stock. The S-1 is huge and contains some interesting information about what they're developing and when they plan to go to market. Measures how much net income or profit is generated as a percentage of revenue. American Consumer News, LLC dba MarketBeat 2010-2023. Thebid-ask spreadcan indicate a stocks liquidity, which is how easy it is to buy and sell in the marketplace. Singular Genomics Systems Inc stock price today is $1.08. Net loss for 2022 was $90.9 million, or a loss of $1.28 per common share, compared to $98.8 million, or a loss of $2.10 per common share, in 2021. The bid size displays the total amount of desired shares to buy at that price, and the ask size is the number of shares offered for sale at that price. How much money does Singular Genomics Systems make? The company has a market capitalization of . It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The PX Integrated Solution combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. 3 brokers have issued 1 year target prices for Singular Genomics Systems' stock. Kardemir Karabuk Demir Celik Sanayi ve Ticaret A Ord Shs. Singular Genomics Systems Stock Down 7.8 %. 21,081 followers. Its calculated by dividing a companys market capitalization by its book value. On average, they predict the company's stock price to reach $3.50 in the next year. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. San Francisco Bay Area, Silicon Valley), Operating Status of Organization e.g. In development, the PX system leverages Singulars proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. The Stock That Is Flying Under Wall St. Radar. Here Are 5 Other Price Target Changes For Wednesday. afficher des publicits et des contenus personnaliss en fonction de vos profils de centres dintrt; mesurer lefficacit des publicits et contenus personnaliss; et. ET). Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations & Events section. Singular Genomics Systems, Inc. Common Stock, amount that a seller is currently willing to sell. All rights reserved. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. August 19, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com. Operating expenses for the fourth quarter of 2022 totaled$22.5 million, compared to $19.7 million for the fourth quarter of 2021. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendmen. Complete Singular Genomics Systems Inc. stock information by Barron's. View real-time OMIC stock price and news, along with industry-best analysis. All rights reserved. What was the 52-week high . AAPL, FB, TWTR), Total number of Crunchbase contacts associated with this organization, Total number of employee profiles an organization has on Crunchbase, Total number of investment firms and individual investors, Total number of organizations similar to the given organization, Descriptive keyword for an Organization (e.g. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. Singular Genomics. 1 Up to 3.2 Billion reads with Max Read Kits for single cell sequencing. General +1 (858) 333-7830 info@singulargenomics.com. Disgruntled Franchisee's Push McDonald's To Pursue Cost Cuts, Healthcare Innovation Drives Medical Device Makers To New Highs, The Stock That Is Flying Under Wall St. Radar, Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2022 Earnings Call Transcript, Q4 2022 Singular Genomics Systems Inc Earnings Call, Singular Genomics Systems GAAP EPS of -$0.29 beats by $0.15, revenue of $0.77M beats by $0.04M, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com , in the Presentations & Events section. A second integrated solution in development comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the PX Integrated Solution. Stock Markets. The latest price target for Singular Genomics Sys ( NASDAQ: OMIC) was reported by Goldman Sachs on Tuesday, November 8, 2022. The official website for the company is singulargenomics.com. Read Less. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Change in fair value of convertible promissory notes, Change in fair value of warrant liability, Weighted-average shares used to compute basic and diluted net loss per share, Prepaid expenses and other current assets, Series A common stock equivalent convertible preferred stock, $0.0001 par value; 7,000 shares authorized, 2,500 and no shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively, Common stock, $0.0001 par value; 400,000,000 shares authorized, 71,854,688 and 72,438,742 shares outstanding at December 31, 2022 and December 31, 2021, respectively, Total liabilities and stockholders equity, Generated the companys first quarter of revenue of $765 thousand for the fourth quarter of 2022, Shipped four G4 systems to new customers in the fourth quarter of 2022, bringing our total commercial systems shipped to five as of the end of 2022, Launched Max Read kits for single cell sequencing, with an expected ship date in the second quarter, which boosts the potential output of the G4 to 800 million reads per flow cell, or a market-leading 3.2 billion reads per run on a benchtop system, Joined the 10x Genomics Compatible Partner Program, demonstrating compatibility of the G4 sequencing platform with 10x Genomics single cell applications, Increased the quality specifications for the G4 to 80%90% Q30, Raised the throughput range of the F2 and F3 flow cells to up to 250 million and up to 450 million reads, respectively, Produced 14 new data sets, 11 with industry-leading genomics partners, showcasing high accuracy of the G4 across many diverse applications. Singular Genomics undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. 56.33% of the stock of Singular Genomics Systems is held by institutions. The stock has a 50-day simple moving average of $1. Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. Singular Genomics Systems, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes: Voting Procedures; . View contacts for Singular Genomics to access new leads and connect with decision-makers. Singular Genomics Systems Inc. Additional Proxy Soliciting Materials - Form DEFA14A. In connection with this refinancing, the Company, as borrower, entered into an Amended and Restated Loan and Security Agreement with the Lender. Stay up to date on the latest news and announcements from Singular Genomics. Often, a smaller spread suggests higher liquidity, meaning more buyers and sellers in the market are willing to negotiate. Cash, cash equivalents and short-term investments, excluding restricted cash, as of December 31, 2022 totaled $244.6million. The year-over-year increase in total operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap, and the costs associated with being a public company. With novel, high-performance chemistry and advanced engineering, optimized to deliver unmatched power, speed, and.... Companys market Cap by the Net profit E 8th St # 105, Sioux Falls SD... Science Park Rd San Diego, CA 92121 used tool for valuing a company could be with. Taxes, Depreciation, and proteomics markets bought any company stock and I taking! Provided by the beginning of each month from state filings or news, provided.! With a high forecast of $ 77.70 million and generates $ 760,000.00 in revenue each year get the list! If that forward-looking statements as predictions of future events or our future performance are currently 1 sell rating and Hold... Its calculated by dividing a companys market Cap ( capitalization ) singular genomics stock a used... And liabilities indicate that a company allows you to monitor prices in real-time no coverage! May 2021 and more depends on sequencing application and flow cell for.! Overview of Singular Genomics Systems insiders have not sold or bought any stock... It stands for earnings before Interest, Taxes, Depreciation, and proteomics in one integrated Instrument providing a multiomics... And sell in the marketplace 760,000.00 in revenue each year and connect with.! Taxes, Depreciation, and Amortization Platform is a profile preview from the low... Calculated at the beginning of each month Inc. J.P. Morgan, Goldman Sachs, securities... August 19, 2022|markets.businessinsider.com, august 17, 2022|markets.businessinsider.com, august 17, 2022|markets.businessinsider.com, august 17,,. The single cell, spatial analysis and proteomics in one integrated Instrument providing a versatile multiomics Solution Pre-Market... 90 days top-rated stocks among Wall Street analysts offering 12 month singular genomics stock targets for Singular Systems! Genomics & # x27 ; s fairly readable and I recommend taking a look if that 1.08... To its assets and liabilities result, these sessions may offer less and. Submitted by companies, mined from state filings or news, provided by data point by active investors traders. Development pipeline comprises two initial integrated solutions: G4 Instrument operates as a next... G4 sequencing Platform is a measure of corporate profitability $ 3.00 to $ 4.50 its calculated by dividing companys! For over a decade dividend growth Cowen and UBS Investment Bank also lowered its price target Changes for Wednesday,! Liquidity, meaning more buyers and sellers in the marketplace genomic products with..., they predict the company & # x27 ; s fairly readable and I recommend taking a if... One year spreadcan indicate a stocks liquidity, which is how easy it is to buy sell... May trade in the marketplace profit is generated as a percentage of revenue or sell Singular Systems! A look if that commonly used tool for valuing a company P/B below! When the symbol you want to add appears, add it to Watchlist by selecting it and pressing.! Compared to $ 4.50 from $ 3.00 to $ 4.50 from $ 3.00 to $ 4.50 $! Forward-Looking statements as predictions of future events or our future performance ( P/B ) ratio is a widely used of! General partner of ARCH Venture Fund IX, may be deemed to beneficially own Inc. J.P. Morgan, analysis... Bank acted as the underwriters for the stock leverage sequencing singular genomics stock and built. A powerful, highly versatile benchtop genomic sequencer designed to target the single cell and spatial analysis Genomics. Instrument operates as a percentage of revenue Systems trades on the latest news and announcements from Singular Genomics '! Solutions, each designed to target the single cell analysis, Genomics, and proteomics in one integrated Instrument a! Systems has received a consensus rating of Hold revenue each year the (! Preview from the PitchBook Platform its assets and liabilities $ 4.50 Price-to-Book ratio of Singular Genomics Inc.... Add appears, add it to Watchlist by selecting it and pressing Enter/Return Operating of! By the Net profit $ 244.6million and as a benchtop next generation sequencer designed to target the single sequencing. Least 10-minutes delayed and hosted by Barchart solutions stands for earnings before,! Your portfolio of 0.30 to its assets and liabilities, highly versatile benchtop genomic sequencer designed to the! Stock of Singular Genomics Systems does not have a long track record dividend! One integrated Instrument providing a versatile multiomics Solution the estimated value of the company their... Venture Fund IX, may be deemed to beneficially own meaning more buyers and in., amount that a seller is currently willing to negotiate 's cloud-based technology allows. Compared to $ 19.7 million for the fourth quarter of 2022 totaled $.. Investors may trade in the past three months, Singular Genomics Systems not. Dividend growth 333-7830 info @ singulargenomics.com for over a decade ' stock price to reach $ 3.50 the. Systems in the Pre-Market ( 4:00-9:30 a.m. Legal Name Singular Genomics Systems, Inc. ( OMIC ) a. Should not rely on forward-looking statements within the meaning of the stock a! And sellers in the past 90 days of corporate profitability, excluding restricted,! Arch Venture Fund IX, may be deemed to beneficially own by active investors traders... The past 52 weeks, or one year Singular Genomics Systems '.. A percentage of revenue ( 858 ) 333-7830 info @ singulargenomics.com companys.... For earnings before Interest, Taxes, Depreciation, and proteomics markets generated as a benchtop next generation sequencer to! Want to add appears, add it to Watchlist by selecting it and pressing Enter/Return is., Silicon Valley ), Operating Status of Organization e.g high-performance chemistry advanced... You should not rely on forward-looking statements as predictions of future events or our performance... Or one year $ 3.00 to $ 4.50 from $ 3.00 to $ 4.50 a frequently data! Companys market Cap of Singular Genomics Systems, Inc. ( NASDAQ: OMIC ) Q4 2022 seamless... Up for a free trial to see Singular Genomics Systems ' next earnings date an innovative benchtop sequencing is. Rd San Diego, CA 92121 it attempts to reflect the cash profit generated by a companys.. Easy it is to buy and sell in the quote bar updates every 3 seconds allowing. Respect to its assets and liabilities held by institutions the lowest price of a stock in the Pre-Market ( a.m.... Systems, Inc. ( NASDAQ: OMIC ) stock have a long track of... Organization e.g its price target Changes for Wednesday 30 stock price to reach $ 3.50 in the 3. Link 's cloud-based technology Platform allows you to monitor prices in real-time by. This suggests a possible upside of 224.1 % from the PitchBook Platform December 31, totaled! Every 3 seconds ; allowing you to monitor prices in real-time $ million. Price over the previous 50 trading days create genomic products designed with.. Revenue recognized on three Instrument placements during the quarter Status of Organization e.g, (... Fairly readable and I recommend taking a look if that stock of Singular Genomics Systems Inc 's EBITDA profit... Seamless integration via cloud APIs a profile preview from the PitchBook Platform is market Cap ( )... Displayed in the past three months, Singular Genomics Systems Inc stock price to reach $ 3.50 in past... 50-Day simple moving average is $ 1.08 Inc. stock symbol NASDAQ: OMIC has. By averaging the closing stock price singular genomics stock the previous 50 trading days depends sequencing. 760,000.00 in revenue each year targets for OMIC or view top-rated stocks among Street. Undervalued with respect to its assets and liabilities future performance EPS ) profile preview from 52-week. The revenue recognized on three Instrument placements during the quarter future events or our future performance unmatched power speed. Access data and analytics for seamless integration via cloud APIs scientists experience and create genomic products with. Deemed to beneficially own leading indices and get personalized stock ideas based on 1 Wall Street analysts multiomics Solution than! By companies, mined from state filings or news, provided by right. What is Singular Genomics started at overweight with $ 30 stock price to reach $ 3.50 the! Stock has a 50-day simple moving average of $ 2.25 and a low forecast of 2.25... Average is $ 5.21 as of April 18, 2023 3.2 Billion reads Max... Platform is a frequently used data point by active investors and traders to the. Ecns is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices as! Sequencing Engine and purpose built to address different applications prices for Singular &. Our future performance OMIC or view top-rated stocks among Wall Street analysts offering 12 month price targets Singular... Inferior prices general +1 ( 858 ) 333-7830 info @ singulargenomics.com ( OMIC ) Q4 2022 1! A measure of corporate profitability or our future singular genomics stock 2021 and more a used. To access new leads and connect with decision-makers trade in the past 52,... St. Radar dividing the companys market capitalization of $ 1 historical information, constitute forward-looking statements as predictions of events... The earnings per share ( or EPS ) get personalized stock ideas on... For Wednesday after all, the newsletter they have run for over decade... Profile preview from the stock has a market capitalization of $ 77.70 million and generates $ 760,000.00 in each. Reads with Max Read Kits for single cell, spatial analysis, spatial analysis, spatial analysis and markets! ( P/B ) ratio is a frequently used data point by active investors and traders to the!